Fig. 2.

Hepatic hMOF in HBeAg⁺ and/or HBeAg⁻ CHB patients and healthy controls. Hepatic hMOF production was presented with Western blot and quantitative analysis of hepatic hMOF mRNA expression was measured by qPCR, from HBeAg⁺ CHB patients (a) and HBeAg⁻ CHB with high HBV DNA load (HBV DNA ≥ 10⁵ IU/mL, 10 cases) and with low HBV DNA load (HBV DNA < 10⁵ IU/mL, 10 cases), and healthy controls (HC) (three cases), and HBeAg⁻ CHB (b) with high HBV DNA load (HBV DNA ≥ 10⁴ IU/mL, 10 cases) and with low HBV DNA load (HBV DNA < 10⁴ IU/mL, 10 cases), and healthy controls (HC) (three cases). The significant difference is expressed as *p < 0.05, **p < 0.01